Trinity Biotech Change in Accounts Payable 2010-2025 | TRIB

Trinity Biotech change in accounts payable from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Trinity Biotech Change in Accounts Payable 2010-2025 | TRIB

Trinity Biotech change in accounts payable from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228B
Boston Scientific (BSX)$152.1B
Stryker (SYK)$144B
EssilorLuxottica (ESLOY)$137.5B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$47.5B
Haleon (HLN)$43B
ResMed (RMD)$41.5B
GE HealthCare Technologies (GEHC)$34B
Agilent Technologies (A)$33.3B
Terumo (TRUMY)$27.6B
Koninklijke Philips (PHG)$26B
Insulet (PODD)$21.8B
Zimmer Biomet Holdings (ZBH)$20.2B
Smith & Nephew SNATS (SNN)$15.9B
Baxter (BAX)$12.3B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.2B
Bio-Rad Laboratories (BIO)$7.4B
Lantheus Holdings (LNTH)$3.7B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.2B
Perrigo (PRGO)$3.2B
ICU Medical (ICUI)$2.7B
Haemonetics (HAE)$2.5B
LeMaitre Vascular (LMAT)$2.1B
Curaleaf Holdings (CURLF)$1.8B
AtriCure (ATRC)$1.8B
Green Thumb Industries (GTBIF)$1.7B